Navy General Hospital — Beijing, Beijing Municipality

Public research footprint of Navy General Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Diffuse Large B-cell Lymphoma · Primary Central Nervous System Lymphoma · Transcatheter Aortic Valve Replacement (TAVR) · B-cell Acute Lymphoblastic Leukemia

Recently updated registry entries

NCT01856478 — LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent… (Completed)
NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease (Recruiting)
NCT06664411 — Pola-ZR2P in Previously Untreated DLBCL (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Navy General Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.